Position in MNOV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$66,728
-$2,527 QoQ
Shares Held
50,552
0.0% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 29 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 37%
Shared 47%
None 17%
Common Shares in MNOV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. MNOV ranks #212 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in MNOV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,728 | 50,552 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $69,255 | 50,552 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $85,168 | 65,015 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $84,092 | 66,215 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $86,740 | 66,215 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $96,673 | 66,215 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $139,050 | 66,215 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $128,697 | 61,285 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $99,894 | 69,372 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $156,155 | 107,694 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $228,794 | 152,530 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $330,097 | 157,942 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $263,976 | 114,773 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $237,676 | 110,036 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $153,759 | 75,005 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $100,034 | 46,099 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $123,144 | 48,674 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $135,032 | 50,574 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $147,011 | 54,855 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $206,676 | 54,532 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $99,747 | 23,470 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $137,683 | 27,264 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $123,946 | 23,564 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $127,997 | 24,427 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $108,773 | 20,069 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $37,609 | 10,110 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||